Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

44.37
-0.6300-1.40%
Post-market: 44.370.00000.00%16:10 EDT
Volume:34.12K
Turnover:1.51M
Market Cap:1.51B
PE:21.03
High:44.84
Open:44.46
Low:44.00
Close:45.00
52wk High:56.59
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:0.42
T/O Rate:0.12%
Dividend:3.01
Dividend Rate:6.78%
EPS(TTM):2.11
EPS(LYR):2.11
ROE:14.08%
ROA:3.79%
PB:2.52
PE(LYR):21.03

Loading ...

Global GP LLC Reports Acquisition of Global Partners LP Common Shares

Reuters
·
Nov 18, 2025

LifeMD Shares Rise on Lower Novo Nordisk GLP-1 Prices

Dow Jones
·
Nov 17, 2025

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

GlobeNewswire
·
Nov 17, 2025

Global Partners (GLP): A Fresh Look at Valuation After Disappointing Quarterly Earnings and Dividend Decision

Simply Wall St.
·
Nov 16, 2025

How Investors Are Reacting To Reinsurance Group of America (RGA) Eyeing GLP-1 Impact and NYC Expansion

Simply Wall St.
·
Nov 15, 2025

Stock Track | Global Partners LP Soars 5.22% Despite Mixed Q3 Earnings, Dividend Stability Praised

Stock Track
·
Nov 15, 2025

Will GLP's Dividend Commitment Reflect Enduring Strength or Reveal Pressure Points in Its Core Operations?

Simply Wall St.
·
Nov 14, 2025

Eli Lilly, Novo Nordisk Make GLP-1 Medications Available Through Mangoceuticals Platform

MT Newswires Live
·
Nov 13, 2025

Citi: Medicare Coverage Changes Everything, Eli Lilly's Oral GLP-1 Drug Sales to Triple Market Forecast Next Year

Deep News
·
Nov 13, 2025

HK Stock Movement | PEGBIO CO-B (02565) Surges Over 15% as GLP-1 Weight-Loss Drug Expands to Middle East and Africa

Stock News
·
Nov 13, 2025

ASCLETIS-B (01672): Monthly-Dose Next-Gen Amylin Receptor Agonist ASC36 and GLP-1R/GIPR Dual-Target Agonist ASC35 Combo Advances to Clinical Development

Stock News
·
Nov 13, 2025

Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development

prnewswire
·
Nov 13, 2025

Global Partners Lp : Stifel Cuts Target Price to $45 From $53

THOMSON REUTERS
·
Nov 11, 2025

Grvt announces the launch of the native protocol treasury Grvt Liquidity Provider (GLP) strategy

Blockbeats
·
Nov 11, 2025

Understanding the GLP-1 Weight-Loss Drug Price Cuts: Goldman Sachs Sees Strategic "Volume-for-Value" Play, Eli Lilly Gains Edge Over Novo Nordisk

Deep News
·
Nov 10, 2025

Global Partners LP Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 08, 2025

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

Dow Jones
·
Nov 08, 2025

Stock Track | Global Partners LP Plummets 5.81% as Q3 Earnings and Revenue Miss Estimates

Stock Track
·
Nov 07, 2025

Stock Track | Global Partners LP Plunges 5% Pre-market on Q3 Earnings Miss and Revenue Shortfall

Stock Track
·
Nov 07, 2025

Stock Track | Global Partners LP Plunges 5.08% Pre-market Following Disappointing Q3 Earnings

Stock Track
·
Nov 07, 2025